81 related articles for article (PubMed ID: 8082008)
1. Response of early growth response genes to renal vasoconstriction.
Rosenberg ME; Hostetter TH
Exp Nephrol; 1994; 2(2):131. PubMed ID: 8082008
[No Abstract] [Full Text] [Related]
2. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin in FK 506-induced renal hypoperfusion in rats.
Kumano K; Chen J; He M; Endo T; Masaki Y
Transplant Proc; 1995 Feb; 27(1):550-3. PubMed ID: 7533423
[No Abstract] [Full Text] [Related]
4. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
Hvistendahl JJ; Pedersen TS; Djurhuus JC; Pedersen EB; Frøkiaer J
Urol Res; 2002 Jul; 30(3):169-77. PubMed ID: 12111180
[TBL] [Abstract][Full Text] [Related]
5. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney.
Rosenberg ME; Hostetter TH
Kidney Int; 1993 Mar; 43(3):601-9. PubMed ID: 8455358
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
Jackson EK; Herzer WA; Vyas SJ; Kost CK
J Pharmacol Exp Ther; 1999 Oct; 291(1):329-34. PubMed ID: 10490921
[TBL] [Abstract][Full Text] [Related]
8. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
9. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
Campese VM; Wurgaft A; Safa M; Bianchi S
J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
[TBL] [Abstract][Full Text] [Related]
10. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
McLaughlin GE; Kashimawo LA; Steele BW; Kuluz JW
Pediatr Crit Care Med; 2003 Jul; 4(3):358-62. PubMed ID: 12831420
[TBL] [Abstract][Full Text] [Related]
11. Pressor and renal angiotensin II responses before and after nephrectomy.
Guidi E; Cozzi MG
J Hum Hypertens; 2009 Jul; 23(7):490-2. PubMed ID: 19225529
[No Abstract] [Full Text] [Related]
12. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
[TBL] [Abstract][Full Text] [Related]
13. FK 506-induced nephrotoxicity in rats.
Kumano K; Wang G; Endo T; Kuwao S
Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
[No Abstract] [Full Text] [Related]
14. Renal effects and vascular reactivity induced by Tityus serrulatus venom.
de Sousa Alves R; do Nascimento NR; Barbosa PS; Kerntopf MR; Lessa LM; de Sousa CM; Martins RD; Sousa DF; de Queiroz MG; Toyama MH; Fonteles MC; Martins AM; Monteiro HS
Toxicon; 2005 Sep; 46(3):271-6. PubMed ID: 16011841
[TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog.
Carrier M; Tronc F; Pelletier LC; Latour JG
J Heart Lung Transplant; 1993; 12(5):851-5. PubMed ID: 8241227
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic cyclosporine therapy on renal vascular reactivity in the isolated perfused rabbit kidney.
Monaco DO; Wait RB; Friedman AL; Kahng KU
Transplant Proc; 1988 Jun; 20(3 Suppl 3):578-83. PubMed ID: 3388502
[No Abstract] [Full Text] [Related]
17. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
[TBL] [Abstract][Full Text] [Related]
18. Renal microvascular actions of calcium antagonists.
Loutzenhiser R; Epstein M
J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
20. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
